Effect of Early Removal of Wound Drains After Mastectomy or Lymph Node Dissection
NCT ID: NCT03104153
Last Updated: 2023-11-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
106 participants
INTERVENTIONAL
2015-09-30
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Clinical : risk of seroma and infection, woundhealing, duration of wound care and drain output versus volume of seroma.
Quality of life : drain-induced pain, discomfort due to seroma or drain, sleep disturbance and implications on daily activities.
Cost-effectiveness
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Output-based
No interventions assigned to this group
Early-removal
Early-drain removal
Drain removal at hospital discharge
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Early-drain removal
Drain removal at hospital discharge
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Female or male
* Age \> 18 years
* All stages of disease (inclusion is independent of TNM-classification)
Exclusion Criteria
* No informed consent: Patient refuses participation OR is not able to give a written informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitaire Ziekenhuizen KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S58129
Identifier Type: -
Identifier Source: org_study_id